Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03263689
Other study ID # MUST/19/08-14
Secondary ID
Status Completed
Phase Phase 3
First received August 16, 2017
Last updated August 23, 2017
Start date March 15, 2014
Est. completion date June 20, 2016

Study information

Verified date August 2017
Source Mbarara University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Many counties in sub-Saharan Africa have very limited post-operative nursing capacity, and relatively little data have been published about post-operative maternal pain control in these settings. Cesarean section is the most common type of major operation at our institution, Mbarara Regional Referral Hospital (MRRH), in south-western Uganda.Nursing ward staffing capacity is low, with much basic nursing care provided by families and friends of patients. The investigators conducted a study to examine the impact of ITM versus TAP block in a setting of limited formal nursing oversight.


Description:

Intrathecal morphine (ITM), administered as a part of spinal anesthesia for caesarian section, can produce significant post-operative analgesia for several hours. The Tranversus Abdominis Plane (TAP) Block can also provide prolonged post-operative pain control. A small number of published studies comparing analgesic outcomes after cesarian section with ITM or TAP block have reported variable results.Moreover, these studies have been conducted in countries with extensive post-operative nursing care.

Many counties in sub-Saharan Africa have very limited post-operative nursing capacity, and relatively little data have been published about post-operative maternal pain control in these settings. Cesarean section is the most common type of major operation at our institution, Mbarara Regional Referral Hospital (MRRH), in south-western Uganda.Nursing ward staffing capacity is low, with much basic nursing care provided by families and friends of patients. The investigators conducted a study to examine the impact of ITM versus TAP block in a setting of limited formal nursing oversight.


Recruitment information / eligibility

Status Completed
Enrollment 130
Est. completion date June 20, 2016
Est. primary completion date June 20, 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

1. Women between the age of 18-45;

2. Greater than 50 kilograms in weight;

3. Routine spinal anesthetic without sedation for an uncomplicated caesarean delivery via a low, transverse abdominal incision (Pfannenstiel);

4. In good health with no major medical problems including gastric ulcers, liver or renal dysfunction

5. Able to communicate freely with a provided non-family member interpreter fluent in the patient's language so that informed consent may be obtained

Exclusion Criteria:

1. Patients with allergies to bupivacaine, paracetamol, or diclofenac;

2. Patients undergoing a surgical approach is other than a low, transverse abdominal incision (Pfannenstiel);

3. Pre-eclampsia, uterine rupture, placental abruption with this pregnancy;

4. Prior complicated abdominal surgery;

5. Medical history of gastric ulcers, liver or kidney dysfunction; and

6. Patient refusal to be involved in the study. Failure to attain informed consent from the patient due to age or level of consciousness

7. Voluntary or involuntary withdraw from the study

8. Referral to another health centre or Hospital for further management.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Intrathecal morphine
ITM group were given 100 micrograms of preservative-free morphine in addition to the local anaesthesia (plain hyperbaric bupivacaine 10mgs) intrathecally during the spinal anaesthesia

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mbarara University of Science and Technology

Outcome

Type Measure Description Time frame Safety issue
Primary Pain measurement Pain measurement using the numerical rating scale (NRS). at 8 hours after intervention
Primary Pain measurement Pain measurement using the numerical rating scale (NRS). at 16 hours after intervention
Primary Pain measurement Pain measurement using the numerical rating scale (NRS) at 24 hours after intervention